UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028286
Receipt number R000032385
Scientific Title The utility of the early intervention by the multi-disciplinary cooperation in the skin reaction due to EGFR inhibitor: Phase II study
Date of disclosure of the study information 2017/09/01
Last modified on 2023/08/24 17:43:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The utility of the early intervention by the multi-disciplinary cooperation in the skin reaction due to EGFR inhibitor: Phase II study

Acronym

The utility of the early intervention by the multi-disciplinary cooperation in the skin reaction due to EGFR inhibitor: Phase II study

Scientific Title

The utility of the early intervention by the multi-disciplinary cooperation in the skin reaction due to EGFR inhibitor: Phase II study

Scientific Title:Acronym

The utility of the early intervention by the multi-disciplinary cooperation in the skin reaction due to EGFR inhibitor: Phase II study

Region

Japan


Condition

Condition

colorectal cancer, head and neck cancer

Classification by specialty

Hepato-biliary-pancreatic medicine Gastrointestinal surgery Oto-rhino-laryngology
Oral surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We appear at high frequency in order of rash, dry skin, perionychia, and the skin reaction with the EGFR (epidermal growth factor receptor) inhibitor often causes the treatment cancellation. Therefore skin reaction measures with the supportive care become important. In the current study, we examine a utility of the early intervention by the multi-disciplinary (dermatologist, medical oncologist, head and neck surgeon, digestive organ surgeon, pharmacist, nurse) cooperation in the skin reaction due to EGFR inhibitor.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Severe skin reaction incidence

Key secondary outcomes

utility of the episode of care sheet
TTF
Chemotherapy cancellation ratio due to the skin reaction


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

We conduct an introduction to the chemotherapy center from diagnosis and treatment department, and, in chemotherapy center, a medical oncologist, a pharmacist or a nurse conducts side effect monitoring using an episode of care sheet (the skin reaction monitoring sheet that we made for the purpose of doing multi-disciplinary cooperation smoothly) at chemotherapy enforcement. By severity of the skin reaction, a tumor physician refers you to a dermatologist, and side effect monitoring, a dermatologist intervene after the next treatment.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who are given EGFR inhibitor with a newcomer

The patients who have experience using EGFR inhibitors, but do not have skin symptoms at the time of re-administration

Key exclusion criteria

The patients that an agreement was not obtained
The patients who have difficulty in side effect monitoring

Target sample size

55


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shohei Sano

Organization

Wakayama Medical University hospital

Division name

Pharmacy

Zip code


Address

811-1, Kimiidera, Wakayama-shi

TEL

073-447-2300

Email

s-sano@wakayama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shohei Sano

Organization

Wakayama Medical University hospital

Division name

Pharmacy

Zip code


Address

811-1, Kimiidera, Wakayama-shi

TEL

073-447-2300

Homepage URL


Email

s-sano@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical University hospital

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

和歌山県立医科大学附属病院(和歌山)Wakayama Medical University hospital


Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 07 Month 21 Day

Date of IRB

2017 Year 09 Month 05 Day

Anticipated trial start date

2017 Year 09 Month 07 Day

Last follow-up date

2022 Year 09 Month 05 Day

Date of closure to data entry

2022 Year 09 Month 05 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 07 Month 19 Day

Last modified on

2023 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032385


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name